Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 FY- Text added to 2018 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Additionaly, Adhansia, Adlon, ALS, amyotrophic, Anatomic, antagonist, anticholinergic, appeal, argued, arithmetic, Bid, burden, Cap, cerebral, chapping, chronic, Circuit, concession, correspondingly, corridor, covertly, deadline, dehydration, diversify, drooling, excessive, explained, fifteen, fluid, foul, furlough, GDPR, Gerald, greatly, harbor, HCl, hereof, HHS, infection, inseverable, Inspector, Ironshore, Jornay, KemPharm, leadership, logistic, main, McLaughlin, mental, metabolite, micro, microparticle, molecule, month, motion, muscarinic, negligible, NeuRx, Northern, NRX, odor, OIG, ompany, oppose, Osomotica, overtly, oxybutynin, PA, palsy, parent, perioral, permission, Pharma, PM, pocket, pre, prolonged, psychosocial, Purdue, realigned, realignment, recasting, receptor, retardation, retention, ROU, salivation, shut, shutdown, sialorrhea, slight, ST, step, stigmatization, stranded, Takeda, therapy, timeframe, unclear, undertaken, upfront, urological, Vermont, worldwide, wrote
Valuein 2017 FY filing- Value in 2018 FY filing
Original filings
Filing view